Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients

Recruiting N/A Interventional Study
Ulcerative Colitis in Remission
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
University of Padova · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This clinical trial aims to learn if the probiotic Prolife 10 Forte could improve the Gut Microbiota composition of Ulcerative colitis patients during the remission phase. The main questions it seeks to answer are: * Does Prolife 10 Forte improve the microbiota composition in patients with Ulcerative colitis? * Is it possible to highlight the variation in microbial pathways? * What clinical param…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of UC confirmed by clinical, endoscopic, and histopathological evidence. Disease in remission phase confirmed by clinical, endoscopic, and histopathological evidence. * Age between 18 and 75 years old. * Ability of the subject to participate fully in all aspects of t…
Contacts

Edoardo V. Savarino, Prof.MD; PhD

0498218720

edoardo.savarino@unipd.it

CONTACT

Sonia Facchin, PhD

0498218720

sonia.facchin@unipd.it

CONTACT